Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$2.03M Sell
19,502
-84,417
-81% -$8.67M 0.39% 60
2020
Q2
$10.2M Sell
103,919
-717
-0.7% -$63.6K 2.06% 23
2020
Q1
$8.15M Sell
104,636
-598
-0.6% -$52.1K 1.9% 24
2019
Q4
$10.3M Buy
105,234
+4,827
+5% +$453K 1.94% 28
2019
Q3
$9.63M Buy
100,407
+3,791
+4% +$415K 1.98% 26
2019
Q2
$11.4M Sell
96,616
-437
-0.5% -$50.9K 2.47% 18
2019
Q1
$12.3M Sell
97,053
-75,865
-44% -$8.52M 2.64% 16
2018
Q4
$14.7M Buy
172,918
+6,222
+4% +$520K 3.6% 5
2018
Q3
$13.4M Buy
+166,696
New +$12.2M 2.99% 8

Other funds holding XLNX

10-15 Associates's XLNX Position: Q3 2020 in Review

10-15 Associates reduced its Xilinx Inc (XLNX) stake by 81% in Q3 2020, selling an estimated $8.67M and leaving 19,502 shares worth $2.03M. The position accounts for 0.39% of the portfolio, ranked #60.

10-15 Associates first reported a position in XLNX in Q3 2018 and has held it in 9 quarters since. The position peaked at $14.7M in Q4 2018. 767 funds tracked by Wall St. Rank hold XLNX as of Q3 2020.

  • 10-15 Associates held 19,502 shares of Xilinx Inc worth $2.03M as of Q3 2020.
  • 10-15 Associates sold 84,417 Xilinx Inc shares in Q3 2020, an estimated $8.67M.
  • Xilinx Inc made up 0.39% of 10-15 Associates's portfolio in Q3 2020, its #60 holding.
  • 10-15 Associates first reported a position in Xilinx Inc in Q3 2018 and has held it in 9 quarters since.
  • 10-15 Associates's Xilinx Inc position peaked at $14.7M in Q4 2018.
  • 767 funds tracked by Wall St. Rank held Xilinx Inc as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.